2019: A Year in Blogging

[N]early three years into the Trump administration, a lot of us are tired. The headlines got more and more draining, culminating in impeachment proceedings at the end of the year. But in response, we’re so fired up that we’re ready to storm the polls next November — and make sure our friends and family do so as well. And 2019 was also a time to be hopeful. In January, a record 102 women walked into the House of Representatives, ready to serve their constituents — making up nearly a quarter of House members, the highest proportion in U.S. history. The Senate saw gains as well, with 25 female senators out of a total of 100. Many of these newcomers made it their mission to fight for the very human and civil rights that are currently under attack.

Outside of politics, we’re still committed to connecting people to the information they need via technology, such as Planned Parenthood’s abortion finder tool, or the Roo app, a sexual-health chatbot that was named by TIME Magazine as one of the year’s best inventions.

Throughout the year, our bloggers were here to shed light on the political happenings and spread awareness about important sexual and reproductive health issues. We asked them to pick their favorite posts of 2019. They’re definitely all worth a second look!

Anne covered the fifth anniversary of the Hobby Lobby decision, which marked the Supreme Court’s ruling that some for-profit corporations could, like human beings, exercise religious beliefs. The Hobby Lobby decision placed religion over science, allowing employers to limit employees’ access to birth control methods otherwise guaranteed by the Affordable Care Act — exploiting a legal loophole to give corporations the right to damage their employees’ health in the name of religion. Five years later, its destructive legacy lives on: The Hobby Lobby decision has since been commandeered to deny birth control, attack the LGBTQ community, make a mess of health care administration, and more.

Matt’s favorite post pointed a spotlight on an important but overshadowed piece of history, the case of People v. Belous, which 50 years ago marked the first time a patient’s constitutional right to abortion was upheld in the courts. The post introduces us to Dr. Leon Belous, a Southern California physician who believed abortion bans were antiquated and barbaric — and was arrested for “conspiracy to commit abortion” after referring a patient to a safe abortion provider in the 1960s. The California Supreme Court vindicated Dr. Belous, setting the stage for Roe v. Wade and the expansion of abortion rights a few years later. As Matt tells us, “I think this case is especially relevant to the borderlands area and the complex role that border towns played in abortion access and the social attitudes toward the procedure.”

Ava wrote about the criminalization of miscarriage. That might not sound possible — the idea that someone could be arrested or imprisoned for having a miscarriage — but plenty of people find themselves in this perplexing and outrageous situation. People who lose their pregnancies may be blamed for these losses if others decide they engaged in risky behaviors, despite the medical fact that most of the time, miscarried or stillborn fetuses die of natural causes, and miscarriage within the first 20 weeks of pregnancy is astonishingly common. These laws may also target people of color, as Black, Latinx, and Native-American people are more likely to experience pregnancy loss than non-Hispanic white people. Simply put, criminalizing pregnancy loss casts pregnant people as vessels rather than people.

Tracey shared her own powerful and personal story about miscarriage. She described that string of four simple words — “I had a miscarriage” — as intimately felt and inconceivable to say. For Tracey, talking about the loss of a baby was almost as hard as losing the baby. She now uses her story to fight stigma, and to encourage other people to do the same. When we are silent around the issue, so many of us suffer in silence, while the reality of the prevalence of miscarriage is distorted for the rest of us. And when people don’t realize how common miscarriage is, they are more likely to blame and demonize those who lose their pregnancies.

Anna celebrated one of 2019’s medical victories, which was announced earlier this year. In her favorite blog post, she introduced readers to the “Berlin patient” and the “London patient,” two people who had HIV before coming down with blood cancers. After receiving bone marrow transplants from donors with genetic “immunity” to HIV, an amazing thing happened: Not only did their cancers go into remission — so did their HIV infections. When this feat was first performed more than a decade ago with the Berlin patient, people were hopeful it could be replicated in future cancer patients — but it took until this year for the success to be duplicated in the London patient. What do these cases mean for the millions of other people living with HIV?


Make your voice heard in 2020! Join our blogging team by becoming a Planned Parenthood Arizona volunteer. We want to help amplify your voice!

STD Awareness: Can Gene Editing Cure HIV?

For the first time in history, someone with HIV has been treated with cells edited in the lab. It was a bold attempt to try to replicate previous successes in “curing” HIV through bone marrow transplants, but the results were a mixed bag.

Your DNA is like a book, and each sentence is a gene. Imagine a word is misspelled. Sometimes, a misspelling won’t affect your ability to understand the sentence, but other times, it will be so bad that you’ll have trouble figuring out the intended meaning. Think of the difference between “I drive a car” and “I driv a car,” or “I like food” and “I like flod.” You might not be able to tell what that last sentence is even trying to say! Those misspellings are mutations, and sometimes mutations are relatively benign (“I driv a car”), while other times they can cause diseases (“I like flod”).


A mutated version of the CCR5 gene confers near-immunity to HIV — but increases susceptibility to other viruses.


CRISPR, pronounced crisper, is a powerful new technology that can edit genes. By cutting DNA at a specific location and replacing some of the letters in the genetic alphabet, CRISPR can edit genes like you can edit a document using “find and replace.” The hope is that, someday, CRISPR could be used to fight disease by tweaking faulty genes. Continue reading

STD Awareness: Can HIV Be Cured Now?

In 1991, when Timothy Ray Brown was in his 20s, he moved from the United States to Europe in search of adventure. His travels brought him to Berlin, where he put down roots and became a translator — but this newfound stability was quickly disrupted. A former boyfriend told him he had been diagnosed with HIV, the virus that causes AIDS, and suggested Brown be tested as well. The results were positive. Brown calculated he had about two more years left to live.

His fortunes changed the next year when antiretroviral drugs transformed HIV from a death sentence to a manageable chronic disease. Life went on. But 10 years later, in 2006, he started noticing changes. While he usually made a 14-mile round trip on his bike to and from work, a quick ride to a café one mile away left him so winded he had to stop halfway through.


We still don’t have an HIV cure that works for everyone.


He was diagnosed with leukemia, a type of cancer that affects certain types of blood cells. He immediately began chemotherapy, a taxing regimen that nearly killed him when an infection forced his doctors to induce a coma. And when the cancer came back, his doctors recommended a bone marrow transplant, which involved wiping out his immune system with drugs and radiation. A year later, after his leukemia came back, he received a second bone marrow transplant. Recovery was grueling. He descended into delirium, nearly went blind, and was temporarily paralyzed. He had to undergo physical therapy to relearn how to walk and talk.

Miraculously, he came out of this near-death experience in full remission from leukemia. But the bone marrow transplants hadn’t just gotten rid of his leukemia. They had gotten rid of his HIV infection, too. The media dubbed him the “Berlin patient.” Continue reading

STD Awareness: The Future of Treatment for HIV/AIDS

This scanning electron micrograph shows HIV particles (colored yellow) infecting a human T cell. Image: National Institute of Allergy and Infectious Diseases, National Institutes of Health

This scanning electron micrograph shows HIV particles (colored yellow) infecting a human T cell. Image: National Institute of Allergy and Infectious Diseases, National Institutes of Health

In 2006, an HIV-positive man was diagnosed with leukemia. First he received chemotherapy, and when the cancer returned his doctor recommended a stem-cell transplant with tissues obtained from a bone-marrow donor. After finding an unusually high number of compatible donors, his doctor, Gero Hütter, had a simple idea that would change the course of HIV research. Dr. Hütter knew of a rare genetic mutation that confers immunity to many strains of HIV, including the strain that infected his cancer patient. And new blood cells, including immune cells, are manufactured by bone marrow. What if he could find a bone-marrow donor with this mutation? What effect would it have on the HIV infection?

Five years after his cancer diagnosis, the man, known as the Berlin patient and recently identified as Timothy Ray Brown, is in remission from cancer … and the most sensitive tests have been unable to detect HIV anywhere in his body, despite the discontinuation of antiretroviral drugs. Scientists are a cautious lot, careful not to make grand statements without qualifying them with words like “seem” and “suggest.” But more and more, researchers are starting to say that Brown could be the first case in which a cure for HIV was attained.

Human immunodeficiency virus, or HIV, has been the focus of intense research since the 1980s, when it was identified as the causative agent of AIDS. Many anti-HIV drugs have been developed since then, though worldwide, less than a third of people who need the drugs have access to them. Those with access, however, have significantly improved health outcomes and longer life expectancy. Continue reading